Difficulty: Medium
Average Score: 90%
Practice
When pupillary dilation-but not cycloplegia-is desired, a good choice is
Correct answer
C
Rationale
In the context of drugs affecting the peripheral nervous system, the correct choice for pupillary dilation without cycloplegia is Phenylephrine (Option C). Phenylephrine is an alpha-1 adrenergic agonist which acts on the dilator muscle of the eye causing mydriasis (pupillary dilation) without affecting accommodation (cycloplegia).
Homatropine (Option A) is a muscarinic antagonist that causes both pupillary dilation and cycloplegia, making it unsuitable for scenarios where only mydriasis is desired. Isoproterenol (Option B) is a non-selective beta-adrenergic agonist that can cause systemic side effects and is not commonly used for pupillary dilation. Pilocarpine (Option D) is a muscarinic agonist that causes miosis (pupillary constriction) and is used to treat conditions like glaucoma, making it the opposite of what is required in this scenario.
Understanding the pharmacological actions of these drugs is crucial for healthcare professionals, especially ophthalmologists and optometrists, to make informed decisions regarding the selection of appropriate medications for specific desired outcomes in clinical practice. Phenylephrine's selective action on the dilator muscle of the eye makes it a preferred choice when pupillary dilation without affecting accommodation is needed.
Homatropine (Option A) is a muscarinic antagonist that causes both pupillary dilation and cycloplegia, making it unsuitable for scenarios where only mydriasis is desired. Isoproterenol (Option B) is a non-selective beta-adrenergic agonist that can cause systemic side effects and is not commonly used for pupillary dilation. Pilocarpine (Option D) is a muscarinic agonist that causes miosis (pupillary constriction) and is used to treat conditions like glaucoma, making it the opposite of what is required in this scenario.
Understanding the pharmacological actions of these drugs is crucial for healthcare professionals, especially ophthalmologists and optometrists, to make informed decisions regarding the selection of appropriate medications for specific desired outcomes in clinical practice. Phenylephrine's selective action on the dilator muscle of the eye makes it a preferred choice when pupillary dilation without affecting accommodation is needed.